Semaglutide Syringe Dosage and Conversion Chart: What You Actually Need to Know

You've got a syringe and a vial marked in ml, here's what's actually happening

Picture this: you've been sent a small glass vial of clear liquid and a box of insulin syringes. The vial label says something like "5 mg/ml" or "2 mg/ml". You've been told your weekly semaglutide dose is 0.25 mg to start. Now you're standing in the kitchen trying to work out how many units to draw up. It's a genuinely confusing place to be.

The core maths is straightforward once you have the concentration. If a vial contains 2 mg of semaglutide per ml of solution, and your prescribed dose is 0.5 mg, you need to draw up 0.25 ml of liquid. Insulin syringes often mark volume in "units" (U-100 calibration), where 100 units equals 1 ml, so 0.25 ml would sit at the 25-unit mark. A different concentration changes every number in that chain. There is no single universal conversion chart for semaglutide syringes precisely because the concentration varies by product and formulation.

The semaglutide dosage chart your prescriber provides should specify the concentration of your product alongside the volume to draw. If it doesn't, ask before injecting anything. The NHS medicines guidance on semaglutide reinforces that preparation instructions must come from the specific product's information, not a generic source. The NHS semaglutide medicines page is a useful starting point for understanding the medicine, though it covers the licensed pen-format products.

Why a genuine Wegovy prescription doesn't involve a syringe at all

This is the part that surprises many people. Wegovy, the brand of semaglutide licensed in the UK specifically for weight management, arrives as a pre-filled injection pen. Each pen is pre-loaded and pre-set to deliver exactly the right dose at the press of a button. You don't measure, you don't draw up, and you don't use a separate syringe.

The licensed dose pathway starts at 0.25 mg weekly and steps up through 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg, with the newer 7.2 mg maintenance dose now also MHRA-approved. Every one of those steps is built into the pen design for that phase of treatment. How Wegovy doses are structured is worth reading if you're early in treatment and uncertain about what comes next.

If someone has supplied you with semaglutide in a vial that requires drawing up into a syringe, that product is not the UK-licensed Wegovy pen. It may be a compounded or unbranded preparation. Compounded semaglutide is not authorised by the MHRA for weight management in the UK. That distinction matters practically: unlicensed preparations have not been through the quality, safety or efficacy review that Wegovy has. The MHRA has flagged the risk of counterfeit and unregulated weight-loss injectables circulating online; any suspected seller operating without clinical oversight should be reported at the Yellow Card scheme.

For those genuinely switching from one licensed form of semaglutide to another, the Wegovy to Ozempic dose comparison page explains why those two products aren't interchangeable for weight management, even though they share the same active molecule.

What the conversion chart question usually means, and what to do instead

Most people searching for a semaglutide syringe conversion chart have landed in one of two situations. Either they're trying to understand an instruction they've already been given and want reassurance they've got it right, or they've sourced semaglutide outside a clinical setting and are trying to figure out the dosing themselves. The second situation carries real risk.

Getting the dose wrong with semaglutide isn't trivial. The titration schedule (starting low and stepping up gradually) exists because GI side effects like nausea, vomiting and diarrhoea are significantly worse if the dose climbs too fast. Going too high too quickly doesn't produce better results; it usually produces a miserable few weeks and people stopping treatment altogether. Understanding semaglutide syringe dosage in practical terms is only safe when the prescriber sets the pace.

If you started on semaglutide elsewhere and are thinking about switching to a properly supervised UK service, a prescriber will ask for evidence of your current dose and titration history before continuing treatment. That's not bureaucracy for its own sake, it's how safe dose progression works. Worth noting: if you're planning to sort this out around a bank holiday or holiday period, some services have cut-off times for same-day review, so factoring in the calendar when you're running low makes sense.

If you're considering liraglutide alongside or instead of semaglutide, the liraglutide to semaglutide dose conversion page covers the clinical comparison; the doses don't translate directly because the two medicines work differently even within the GLP-1 class.

For people new to treatment entirely, the weight-loss treatment overview sets out what the licensed options are, who they're suitable for, and the clinical process involved. Semaglutide is a prescription-only medicine; every legitimate route to it starts with a proper clinical assessment.